Buy Cabotib 60mg Cabozantinib

Cabotib 60mg tablets contain cabozantinib, a kinase inhibitor used for cancer therapy. This oral medication is prescribed for adults managing advanced renal cell carcinoma or other solid tumors. Store at room temperature and follow healthcare provider guidance.

Strength

60mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

BDR Pharmaceuticals Int'l Pvt Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Cabotib 60mg is prescribed to treat advanced kidney cancer and other solid tumors in adults. It belongs to a class of medications that help slow tumor growth by targeting specific proteins. Patients may use it when other treatments are no longer effective. Always consult a doctor for personalized advice.

Side Effects

Cabotib 60mg works by interfering with signals that cancer cells use to grow and spread. Common effects include fatigue, decreased appetite, and changes in taste. Some patients may experience digestive discomfort or weight loss during treatment.

Precautions & Warnings

Keep Cabotib 60mg in its original packaging away from moisture and direct sunlight. Store at room temperature and avoid crushing or splitting tablets unless directed. Handle with care and keep out of reach of children and pets. Report any unusual symptoms to a healthcare professional promptly.

Avoid Interactions

Cabotib 60mg may interact with strong CYP3A4 inhibitors or inducers, altering its effectiveness. Avoid grapefruit products and certain supplements like St. John’s wort. Inform your doctor about all medications, including over-the-counter drugs and herbal products, before starting treatment.

References

Frequently Asked Questions

Cabozantinib is primarily used to treat advanced kidney cancer and other solid tumors in adults.

Store Cabotib 60mg at room temperature in its original packaging, away from moisture and direct light.

Do not crush or split Cabotib 60mg tablets unless specifically instructed by your healthcare provider.

Common side effects may include fatigue, decreased appetite, and digestive discomfort.

Yes, it may interact with CYP3A4 inhibitors, inducers, and grapefruit products. Always inform your doctor about all medications you take.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.